A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age

被引:23
|
作者
Lee, Evelyn [1 ]
Costello, Michael F. [2 ]
Botha, Willings C. [3 ]
Illingworth, Peter [4 ]
Chambers, Georgina M. [5 ]
机构
[1] Univ New South Wales, Ctr Social Res Hlth, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[3] Univ New South Wales, Ctr Big Data Res Hlth, Natl Perinatal Epidemiol & Stat, Sydney, NSW, Australia
[4] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[5] IVF Australia Pty Ltd, Sydney, NSW, Australia
关键词
aneuploidy; assisted reproductive technology; cost-effectiveness analysis; cumulative live-birth rate; preimplantation genetic diagnosis;
D O I
10.1111/ajo.12988
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Current evidence suggests that preimplantation genetic testing for aneuploidy (PGT-A) used during assisted reproductive technology improves per-cycle live-birth rates but cumulative live-birth rate (CLBR) was similar to a strategy of morphological assessment (MA) of embryos. No study has assessed the cost-effectiveness of repeated cycles with PGT-A using longitudinal patient-level data. Aim To assess the cost-effectiveness of repeated cycles with PGT-A compared to MA of embryos in older women. Materials and Methods Micro-costing methods were used to value direct resource consumption of 2093 assisted reproductive technology-naive women aged >= 37 years undergoing up to three 'complete assisted reproductive technology cycles' (fresh plus cryopreserved embryos) with either PGT-A or MA in an Australian clinic between 2011 and 2014. Incremental cost-effective ratios were calculated from healthcare and patient perspectives with uncertainty assessed using non-parametric bootstrap methods. Cost-effectiveness acceptability curves were constructed to evaluate the probability of PGT-A being cost-effective over a range of willingness-to-pay thresholds. Results The CLBR and mean healthcare costs per patient were 30.90% and $22 962 for the PGT-A group, and 26.77% and $21 801 for the MA group, yielding an incremental cost-effective ratio of $28 103 for an additional live birth with PGT-A. At a willingness-to-pay threshold of $50 000 and above, there is more than an 80% probability of PGT-A being cost-effective from the healthcare perspective and a 50% likelihood from a patient perspective. Conclusion This is the first study to use real-world patient-level data to assess the cost-effectiveness of PGT-A in older women from the healthcare and patient perspectives. The findings contribute to the ongoing debate on the role of PGT-A in clinical practice.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 44 条
  • [21] Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage
    Lee, Chun-, I
    Wu, Cheng-Hsuan
    Pai, Yi-Ping
    Chang, Yu-Jun
    Chen, Chung-, I
    Lee, Tsung-Hsien
    Lee, Maw-Sheng
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (02): : 239 - 243
  • [22] A COST-EFFECTIVENESS ANALYSIS OF GESTATIONAL CARRIERS FOR INFERTILE WOMEN OF VERY ADVANCED MATERNAL AGE
    Bavan, Brindha
    Cheng, Hannah
    Phibbs, Ciaran
    Leonard, Stephanie
    Lyell, Deirdre
    Murugappan, Gayathree
    FERTILITY AND STERILITY, 2021, 116 (01) : E43 - E44
  • [23] Utilization of standardized preimplantation genetic testing for aneuploidy (PGT-A) via artificial intelligence (AI) technology is correlated with improved pregnancy outcomes in single thawed euploid embryo transfer (STEET) cycles
    Buldo-Licciardi, Julia
    Large, Michael J. J.
    McCulloh, David H. H.
    McCaffrey, Caroline
    Grifo, James A. A.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2023, 40 (02) : 289 - 299
  • [24] Utilization of standardized preimplantation genetic testing for aneuploidy (PGT-A) via artificial intelligence (AI) technology is correlated with improved pregnancy outcomes in single thawed euploid embryo transfer (STEET) cycles
    Julia Buldo-Licciardi
    Michael J. Large
    David H. McCulloh
    Caroline McCaffrey
    James A. Grifo
    Journal of Assisted Reproduction and Genetics, 2023, 40 : 289 - 299
  • [25] Early pregnancy outcomes associated with age and AMH following Next-Generation Sequencing(NGS)-based Preimplantation Genetic Testing for Aneuploidy(PGT-A) in single euploid embryo transfers for advanced age patients
    Kim, Y. I.
    Yang, N. R.
    Han, S. J.
    Kim, J. H.
    Yu, E. J.
    Hur, Y. J.
    Kim, M. J.
    Kang, K. Y.
    Park, E. A.
    Lee, H. C.
    Kim, H. O.
    Kim, Y. S.
    Yoon, T. K.
    HUMAN REPRODUCTION, 2024, 39 : I450 - I450
  • [26] Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial
    He, Xuan
    Wang, Xiao
    Shen, Jiaojie
    Wan, Bin
    Wang, Yingpeng
    Zhang, Zhuolin
    Cai, Lele
    Bao, Yuwen
    Ding, Haixia
    Li, Xin
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [27] Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial
    Xuan He
    Xiao Wang
    Jiaojie Shen
    Bin Wan
    Yingpeng Wang
    Zhuolin Zhang
    Lele Cai
    Yuwen Bao
    Haixia Ding
    Xin Li
    BMC Pregnancy and Childbirth, 23
  • [28] First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis
    Waites, Bethany T.
    Walker, Allison R.
    Skeith, Ashley A.
    Caughey, Aaron B.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (21): : 4123 - 4129
  • [29] Different Strategies of Preimplantation Genetic Testing for Aneuploidies in Women of Advanced Maternal Age: A Systematic Review and Meta-Analysis
    Shi, Wei-Hui
    Jiang, Zi-Ru
    Zhou, Zhi-Yang
    Ye, Mu-Jin
    Qin, Ning-Xin
    Huang, He-Feng
    Chen, Song-Chang
    Xu, Chen-Ming
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [30] A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size
    Bakkensen, Jennifer B.
    Flannagan, Kerry S. J.
    Mumford, Sunni L.
    Hutchinson, Anne P.
    Cheung, Elaine O.
    Moreno, Patricia I.
    Jordan, Neil
    Feinberg, Eve C.
    Goldman, Kara N.
    FERTILITY AND STERILITY, 2022, 118 (05) : 875 - 884